NCT04330651 Post-Surgery Extracorporeal Life Support
| NCT ID | NCT04330651 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florence |
| Condition | Cardiogenic Shock |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2004-01 |
| Primary Completion | 2021-03-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2004-01 with a primary completion date of 2021-03-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Extracorporeal Life Support (ECLS) may provide pulmonary and circulatory support for patients with acute heart failure refractory to conventional medical therapy. However, indications and effectiveness of ECLS engagement post-surgery remains a concern. The investigators sought to analyze indications, modality and outcomes of PS-ECLS, to identify predictors of early and midterm survival after PS-ECLS. The investigators have recorded prospectively, and analysed data of 209 consecutive PS-ECLS patients between January 2004 and December 2018. Demographic and clinical data before, during and after PS-ECLS were collected and their influence on hospital mortality and outcomes (early and midterm) will analyse. Multivariate analysis of pre PS-ECLS implantation factors (as age, female sex , insulin-dependent diabetes, pulmonary hypertension, STS, type of surgical procedure data, pre-ECLS blood lactate level) will be made for identify prognostic risk factors of in-hospital mortality. Overall survival will be analysed, at 6 months,1-year and 5-years, respectively and the factors influencing mild/term outcome will be investigated.
Eligibility Criteria
Inclusion Criteria: * Patients underwent cardiac surgery Exclusion Criteria: * Age \< 18 years
Frequently Asked Questions
Who can join the NCT04330651 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Cardiogenic Shock. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04330651 currently recruiting?
Yes, NCT04330651 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Florence to inquire about joining.
Where is the NCT04330651 trial being conducted?
This trial is being conducted at Florence, Italy.
Who is sponsoring the NCT04330651 clinical trial?
NCT04330651 is sponsored by University of Florence. The trial plans to enroll 500 participants.